HTLV-1 bZIP factor supports proliferation of adult T cell leukemia cells through suppression of C/EBPα signaling

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Zhao, Tiejun ^a,b   Coutts, Aaron ^b,d   Xu, Lingling ^a   Yu, Juntao ^a   Ohshima, Koichi ^c   Matsuoka, Masao ^b  

^a ZHEJIANG NORMAL UNIVERSITY   (China)

^b KYOTO UNIVERSITY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

C EBP ; HBZ; HTLV 1

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CCAAT ENHANCER BINDING PROTEIN ALPHA; DNA; LUCIFERASE; SMAD3 PROTEIN; TAX PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; DNA BINDING; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; T CELL LEUKEMIA; TRANSCRIPTION REGULATION;

HUMAN T-LYMPHOTROPIC VIRUS 1;

ADULT; AGED; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE; CELL PROLIFERATION; DNA; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; PROTEIN BINDING; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 84890542889     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-159     Document Type: Article

References (57)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977, 50:481-492.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77:7415-7419. 10.1073/pnas.77.12.7415, 350514, 6261256.
3. Journo C, Douceron E, Mahieux R. HTLV gene regulation: because size matters, transcription is not enough. Future Microbiol 2009, 4:425-440. 10.2217/fmb.09.13, 19416012.
4. Grassmann R, Aboud M, Jeang KT. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005, 24:5976-5985. 10.1038/sj.onc.1208978, 16155604.
5. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007, 7:270-280. 10.1038/nrc2111, 17384582.
6. Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard JM. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 2002, 76:12813-12822. 10.1128/JVI.76.24.12813-12822.2002, 136662, 12438606.
7. Satou Y, Yasunaga J, Yoshida M, Matsuoka M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci USA 2006, 103:720-725. 10.1073/pnas.0507631103, 1334651, 16407133.
8. Zhao T, Matsuoka M. HBZ and its roles in HTLV-1 oncogenesis. Front Microbiol 2012, 3:247. 3391691, 22787458.
9. Douceron E, Kaidarova Z, Miyazato P, Matsuoka M, Murphy EL, Mahieux R. HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis. J Infect Dis 2012, 205:82-86. 10.1093/infdis/jir708, 3242747, 22065675.
10. Halin M, Douceron E, Clerc I, Journo C, Ko NL, Landry S, Murphy EL, Gessain A, Lemasson I, Mesnard JM, et al. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. Blood 2009, 114:2427-2438. 10.1182/blood-2008-09-179879, 2746472, 19602711.
11. Lemasson I, Lewis MR, Polakowski N, Hivin P, Cavanagh MH, Thebault S, Barbeau B, Nyborg JK, Mesnard JM. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol 2007, 81:1543-1553. 10.1128/JVI.00480-06, 1797566, 17151132.
12. Matsumoto J, Ohshima T, Isono O, Shimotohno K. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein. Oncogene 2005, 24:1001-1010. 10.1038/sj.onc.1208297, 15592508.
13. Zhao T, Yasunaga J, Satou Y, Nakao M, Takahashi M, Fujii M, Matsuoka M. Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB. Blood 2009, 113:2755-2764. 10.1182/blood-2008-06-161729, 19064727.
14. Zhao T, Satou Y, Sugata K, Miyazato P, Green PL, Imamura T, Matsuoka M. HTLV-1 bZIP factor enhances TGF-beta signaling through p300 coactivator. Blood 2011, 118:1865-1876. 10.1182/blood-2010-12-326199, 3158717, 21705495.
15. Ma G, Yasunaga J, Fan J, Yanagawa S, Matsuoka M. HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells. Oncogene 2012, 32:4222-4230.
16. Ramji DP, Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002, 365:561-575. 1222736, 12006103.
17. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol 2007, 17:318-324. 10.1016/j.tcb.2007.07.004, 17658261.
18. Tsukada J, Yoshida Y, Kominato Y, Auron PE. The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation. Cytokine 2011, 54:6-19. 10.1016/j.cyto.2010.12.019, 21257317.
19. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 1997, 94:569-574. 10.1073/pnas.94.2.569, 19554, 9012825.
20. Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer. Cancer Res 2002, 62:528-534.
21. Fuchs O. Growth-inhibiting activity of transcription factor C/EBPalpha, its role in haematopoiesis and its tumour suppressor or oncogenic properties in leukaemias. Folia Biol (Praha) 2007, 53:97-108.
22. Chapiro E, Russell L, Radford-Weiss I, Bastard C, Lessard M, Struski S, Cave H, Fert-Ferrer S, Barin C, Maarek O, et al. Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. Blood 2006, 108:3560-3563. 10.1182/blood-2006-03-010835, 16873674.
23. Paz-Priel I, Ghosal AK, Kowalski J, Friedman AD. C/EBPalpha or C/EBPalpha oncoproteins regulate the intrinsic and extrinsic apoptotic pathways by direct interaction with NF-kappaB p50 bound to the bcl-2 and FLIP gene promoters. Leukemia 2009, 23:365-374. 10.1038/leu.2008.297, 2640433, 18987666.
24. Pise-Masison CA, Dittmer J, Clemens KE, Brady JN. Physical and functional interaction between the human T-cell lymphotropic virus type 1 Tax1 protein and the CCAAT binding protein NF-Y. Mol Cell Biol 1997, 17:1236-1243. 231848, 9032250.
25. Hivin P, Gaudray G, Devaux C, Mesnard JM. Interaction between C/EBPbeta and Tax down-regulates human T-cell leukemia virus type I transcription. Virology 2004, 318:556-565. 10.1016/j.virol.2003.10.027, 14972524.
26. Tsukada J, Misago M, Serino Y, Ogawa R, Murakami S, Nakanishi M, Tonai S, Kominato Y, Morimoto I, Auron PE, Eto S. Human T-cell leukemia virus type I Tax transactivates the promoter of human prointerleukin-1beta gene through association with two transcription factors, nuclear factor-interleukin-6 and Spi-1. Blood 1997, 90:3142-3153.
27. Pise-Masison CA, Radonovich M, Dohoney K, Morris JC, O'Mahony D, Lee MJ, Trepel J, Waldmann TA, Janik JE, Brady JN. Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood 2009, 113:4016-4026. 10.1182/blood-2008-08-175901, 2673128, 19131553.
28. Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, Matsuda Y, Sato-Otsubo A, Muto S, Utsunomiya A, et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 2012, 21:121-135. 10.1016/j.ccr.2011.12.015, 22264793.
29. Grant C, Nonnemacher M, Jain P, Pandya D, Irish B, Williams SC, Wigdahl B. CCAAT/enhancer-binding proteins modulate human T cell leukemia virus type 1 long terminal repeat activation. Virology 2006, 348:354-369. 10.1016/j.virol.2005.12.024, 16458341.
30. Hagiya K, Yasunaga J, Satou Y, Ohshima K, Matsuoka M. ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells. Retrovirology 2011, 8:19. 10.1186/1742-4690-8-19, 3068935, 21414204.
31. Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, Shimizu K, Ohshima K, Green PL, Ohkura N, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. Plos Pathogens 2011, 7:e1001274. 10.1371/journal.ppat.1001274, 3037353, 21347344.
32. Choy L, Derynck R. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J Biol Chem 2003, 278:9609-9619. 10.1074/jbc.M212259200, 12524424.
33. Nerlov C. C/EBPs: recipients of extracellular signals through proteome modulation. Curr Opin Cell Biol 2008, 20:180-185. 10.1016/j.ceb.2008.02.002, 18358708.
34. Fan J, Ma G, Nosaka K, Tanabe J, Satou Y, Koito A, Wain-Hobson S, Vartanian JP, Matsuoka M. APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo. J Virol 2010, 84:7278-7287. 10.1128/JVI.02239-09, 2898234, 20463074.
35. Matsuoka M. Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2005, 2:27. 10.1186/1742-4690-2-27, 1131926, 15854229.
36. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001, 19:475-496. 10.1146/annurev.immunol.19.1.475, 11244044.
37. Mulloy JC, Kislyakova T, Cereseto A, Casareto L, LoMonico A, Fullen J, Lorenzi MV, Cara A, Nicot C, Giam C, Franchini G. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J Virol 1998, 72:8852-8860. 110302, 9765430.
38. Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G, Sato S, Morita M, Kidokoro M, Sugimoto M, et al. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol 1991, 3:761-767. 10.1093/intimm/3.8.761, 1911545.
39. Pulikkan JA, Dengler V, Peramangalam PS, Peer Zada AA, Muller-Tidow C, Bohlander SK, Tenen DG, Behre G. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010, 115:1768-1778. 10.1182/blood-2009-08-240101, 2832809, 20029046.
40. Lu GD, Leung CH, Yan B, Tan CM, Low SY, Aung MO, Salto-Tellez M, Lim SG, Hooi SC. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation. Gastroenterology 2010, 139:632-643. 643 e631-634, 10.1053/j.gastro.2010.03.051, 20347819.
41. White JD, Zaknoen SL, Kasten-Sportes C, Top LE, Navarro-Roman L, Nelson DL, Waldmann TA. Infectious complications and immunodeficiency in patients with human T-cell lymphotropic virus I-associated adult T-cell leukemia/lymphoma. Cancer 1995, 75:1598-1607. 10.1002/1097-0142(19950401)75:7<1598::AID-CNCR2820750708>3.0.CO;2-7, 8826916.
42. Nicot C. Current views in HTLV-I-associated adult T-cell leukemia/lymphoma. Am J Hematol 2005, 78:232-239. 10.1002/ajh.20307, 15726602.
43. Sugata K, Satou Y, Yasunaga J, Hara H, Ohshima K, Utsunomiya A, Mitsuyama M, Matsuoka M. HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines. Blood 2012, 119:434-444. 10.1182/blood-2011-05-357459, 3257009, 22123848.
44. Shimatani K, Nakashima Y, Hattori M, Hamazaki Y, Minato N. PD-1+ memory phenotype CD4+ T cells expressing C/EBPalpha underlie T cell immunodepression in senescence and leukemia. Proc Natl Acad Sci USA 2009, 106:15807-15812. 10.1073/pnas.0908805106, 2739871, 19805226.
45. Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, Dolcetti L, Ugel S, Sonda N, Bicciato S, Falisi E, et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010, 32:790-802. 10.1016/j.immuni.2010.05.010, 20605485.
46. Choi BH, Park GT, Rho HM. Interaction of hepatitis B viral X protein and CCAAT/ enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter. J Biol Chem 1999, 274:2858-2865. 10.1074/jbc.274.5.2858, 9915821.
47. Bristol JA, Robinson AR, Barlow EA, Kenney SC. The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteins. J Virol 2010, 84:12362-12374. 10.1128/JVI.00712-10, 2976414, 20861254.
48. Liu Y, Nonnemacher MR, Wigdahl B. CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection. Future Microbiol 2009, 4:299-321. 10.2217/fmb.09.4, 2710768, 19327116.
49. Wang SE, Wu FY, Yu Y, Hayward GS. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters. J Virol 2003, 77:9590-9612. 10.1128/JVI.77.17.9590-9612.2003, 187379, 12915572.
50. Nishitsuji H, Funami K, Shimizu Y, Ujino S, Sugiyama K, Seya T, Takaku H, Shimotohno K. HCV infection induces inflammatory cytokines and chemokines mediated by the cross-talk between hepatocytes and stellate cells. J Virol 2013, 87:8169-8178. 10.1128/JVI.00974-13, 3700210, 23678168.
51. Fields J, Gardner-Mercer J, Borgmann K, Clark I, Ghorpade A. CCAAT/enhancer binding protein beta expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1. J Neurochem 2011, 118:93-104. 10.1111/j.1471-4159.2011.07203.x, 3112278, 21281310.
52. Zhi HJ, Yang LP, Kuo YL, Ho YK, Shih HM, Giam CZ. NF-kappa B Hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ. Plos Pathogens 2011, 7:e1002025. 10.1371/journal.ppat.1002025, 3084201, 21552325.
53. Kuhlmann AS, Villaudy J, Gazzolo L, Castellazzi M, Duc Dodon M. HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT). Retrovirology 2007, 4:92. 10.1186/1742-4690-4-92, 2235888, 18078517.
54. Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massague J. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 2006, 10:203-214. 10.1016/j.ccr.2006.07.019, 16959612.
55. Yamamoto-Taguchi N, Satou Y, Miyazato P, Ohshima K, Nakagawa M, Katagiri K, Kinashi T, Matsuoka M. HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression. PLoS Pathog 2013, 9:e1003630. 10.1371/journal.ppat.1003630, 3777874, 24068936.
56. Jazag A, Kanai F, Ijichi H, Tateishi K, Ikenoue T, Tanaka Y, Ohta M, Imamura J, Guleng B, Asaoka Y, et al. Single small-interfering RNA expression vector for silencing multiple transforming growth factor-beta pathway components. Nucleic Acids Res 2005, 33:e131. 10.1093/nar/gni130, 1188087, 16113239.
57. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000, 7:1063-1066. 10.1038/sj.gt.3301206, 10871756.